Hypertrophy induced KIF5B controls mitochondrial localization and function in neonatal rat cardiomyocytes

Journal of Molecular and Cellular Cardiology

Volumn 97, Issue , 2016, Pages 70-81

  Tigchelaar, Wardit ^a   de Jong, Anne Margreet ^a   Bloks, Vincent W ^a   van Gilst, Wiek H ^a   de Boer, Rudolf A ^a   Silljé, Herman H W ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cardiomyocyte; Heart; Hypertrophy; Kif5b; Mitochondria

Indexed keywords

KINESIN 5; KINESIN FAMILY MEMBER 5B; PHENYLEPHRINE; SOMATOMEDIN C; UNCLASSIFIED DRUG; INSULIN-LIKE GROWTH FACTOR-1, RAT; KIF5B PROTEIN, RAT; KINESIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE);

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIAC MUSCLE CELL; CELL MEMBRANE PERMEABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ACTIVITY; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HEART HYPERTROPHY; KINESIN FAMILY MEMBER 5B GENE; MALE; MITOCHONDRIAL ENERGY TRANSFER; MOLECULAR PATHOLOGY; NEWBORN; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; ANIMAL; CARDIOMEGALY; CELL CULTURE; CELL RESPIRATION; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HEART MITOCHONDRION; METABOLISM; ORGANELLE BIOGENESIS;

ANIMALS; ANIMALS, NEWBORN; CARDIOMEGALY; CELL RESPIRATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT COMPLEX I; ELECTRON TRANSPORT COMPLEX II; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INSULIN-LIKE GROWTH FACTOR I; KINESIN; MALE; MITOCHONDRIA, HEART; MYOCYTES, CARDIAC; ORGANELLE BIOGENESIS; PHENYLEPHRINE; RATS;

EID: 84966728178     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2016.04.005     Document Type: Article

References (52)

1. Barry S.P., Davidson S.M., Townsend P.A. Molecular regulation of cardiac hypertrophy. Int. J. Biochem. Cell Biol. 2008, 40:2023-2039.
2. Frey N., Katus H.A., Olson E.N., Hill J.A. Hypertrophy of the heart: a new therapeutic target?. Circulation 2004, 109:1580-1589.
3. Bernardo B.C., Weeks K.L., Pretorius L., McMullen J.R. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol. Ther. 2010, 128:191-227.
4. De Boer R.A., Pinto Y.M., Van Veldhuisen D.J. The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities. Microcirculation 2003, 10:113-126.
5. Lai L., Leone T.C., Keller M.P., Martin O.J., Broman A.T., Nigro J., et al. Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach. Circ. Heart Fail. 2014, 7:1022-1031.
6. Kienesberger P.C., Pulinilkunnil T., Nagendran J., Dyck J.R. Myocardial triacylglycerol metabolism. J. Mol. Cell. Cardiol. 2013, 55:101-110.
7. Kolwicz S.C., Tian R. Glucose metabolism and cardiac hypertrophy. Cardiovasc. Res. 2011, 90:194-201.
8. Lehman J.J., Kelly D.P. Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth. Heart Fail. Rev. 2002, 7:175-185.
9. O'Neill B.T., Kim J., Wende A.R., Theobald H.A., Tuinei J., Buchanan J., et al. A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy. Cell Metab. 2007, 6:294-306.
10. Abel E.D., Doenst T. Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy. Cardiovasc. Res. 2011, 90:234-242.
11. Rosca M.G., Tandler B., Hoppel C.L. Mitochondria in cardiac hypertrophy and heart failure. J. Mol. Cell. Cardiol. 2013, 55:31-41.
12. Lu B., Mahmud H., Maass A.H., Yu B., van Gilst W.H., de Boer R.A., et al. The Plk1 inhibitor BI 2536 temporarily arrests primary cardiac fibroblasts in mitosis and generates aneuploidy in vitro. PLoS One 2010, 5.
13. Lu B., Yu H., Zwartbol M., Ruifrok W.P., van Gilst W.H., de Boer R.A., et al. Identification of hypertrophy- and heart failure-associated genes by combining in vitro and in vivo models. Physiol. Genomics 2012, 44:443-454.
14. de Boer R.A., Pokharel S., Flesch M., van Kampen D.A., Suurmeijer A.J., Boomsma F., et al. Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27. J. Mol. Med. 2004, 82:678-687.
15. Muller O.J., Lange M., Rattunde H., Lorenzen H.P., Muller M., Frey N., et al. Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload. Cardiovasc. Res. 2003, 59:380-389.
16. Salabei J.K., Gibb A.A., Hill B.G. Comprehensive measurement of respiratory activity in permeabilized cells using extracellular flux analysis. Nat. Protoc. 2014, 9:421-438.
17. Tigchelaar W., Yu H., de Jong A.M., van Gilst W.H., van der Harst P., Westenbrink B.D., et al. Loss of mitochondrial exo/endonuclease EXOG affects mitochondrial respiration and induces ROS-mediated cardiomyocyte hypertrophy. Am. J. Physiol. Cell Physiol. 2015, 308:C155-C163.
18. Lin K., Kools H., de Groot P.J., Gavai A.K., Basnet R.K., Cheng F., et al. MADMAX - management and analysis database for multiple ~omics experiments. J. Integr. Bioinform. 2011, 8:160. (jib-2011-160).
19. Sartor M.A., Tomlinson C.R., Wesselkamper S.C., Sivaganesan S., Leikauf G.D., Medvedovic M. Intensity-based hierarchical Bayes method improves testing for differentially expressed genes in microarray experiments. BMC Bioinf. 2006, 7:538.
20. Storey J.D., Tibshirani R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:9440-9445.
21. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
22. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:15545-15550.
23. De Jong A.M., Van Gelder I.C., Vreeswijk-Baudoin I., Cannon M.V., Van Gilst W.H., Maass A.H. Atrial remodeling is directly related to end-diastolic left ventricular pressure in a mouse model of ventricular pressure overload. PLoS One 2013, 8.
24. Lee M.A., Bohm M., Paul M., Bader M., Ganten U., Ganten D. Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27. Am. J. Phys. 1996, 270:E919-E929.
25. Sharov V.G., Todor A.V., Silverman N., Goldstein S., Sabbah H.N. Abnormal mitochondrial respiration in failed human myocardium. J. Mol. Cell. Cardiol. 2000, 32:2361-2367.
26. Strom C.C., Aplin M., Ploug T., Christoffersen T.E., Langfort J., Viese M., et al. Expression profiling reveals differences in metabolic gene expression between exercise-induced cardiac effects and maladaptive cardiac hypertrophy. FEBS J. 2005, 272:2684-2695.
27. Dorn G.W. Mitochondrial dynamics in heart disease. Biochim. Biophys. Acta 1833, 2013:233-241.
28. Dorn G.W. Mitochondrial dynamism and heart disease: changing shape and shaping change. EMBO Mol. Med. 2015, 7:865-877.
29. Yano M., Kanazawa M., Terada K., Takeya M., Hoogenraad N., Mori M. Functional analysis of human mitochondrial receptor Tom20 for protein import into mitochondria. J. Biol. Chem. 1998, 273:26844-26851.
30. Pagliarini D.J., Calvo S.E., Chang B., Sheth S.A., Vafai S.B., Ong S.E., et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell 2008, 134:112-123.
31. Yao L.L., Wang Y.G., Liu X.J., Zhou Y., Li N., Liu J., et al. Phenylephrine protects cardiomyocytes from starvation-induced apoptosis by increasing glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activity. J. Cell. Physiol. 2012, 227:3518-3527.
32. Zhu H., McElwee-Witmer S., Perrone M., Clark K.L., Zilberstein A. Phenylephrine protects neonatal rat cardiomyocytes from hypoxia and serum deprivation-induced apoptosis. Cell Death Differ. 2000, 7:773-784.
33. Tanaka Y., Kanai Y., Okada Y., Nonaka S., Takeda S., Harada A., et al. Targeted disruption of mouse conventional kinesin heavy chain, kif5B, results in abnormal perinuclear clustering of mitochondria. Cell 1998, 93:1147-1158.
34. Fang L., Moore X.L., Gao X.M., Dart A.M., Lim Y.L., Du X.J. Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo. Life Sci. 2007, 80:2154-2160.
35. Pennanen C., Parra V., Lopez-Crisosto C., Morales P.E., Del Campo A., Gutierrez T., et al. Mitochondrial fission is required for cardiomyocyte hypertrophy mediated by a Ca2+-calcineurin signaling pathway. J. Cell Sci. 2014, 127:2659-2671.
36. Tang Y., Mi C., Liu J., Gao F., Long J. Compromised mitochondrial remodeling in compensatory hypertrophied myocardium of spontaneously hypertensive rat. Cardiovasc. Pathol. 2014, 23:101-106.
37. Chen L., Gong Q., Stice J.P., Knowlton A.A. Mitochondrial OPA1, apoptosis, and heart failure. Cardiovasc. Res. 2009, 84:91-99.
38. Schaper J., Froede R., Hein S., Buck A., Hashizume H., Speiser B., et al. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 1991, 83:504-514.
39. Lalioti V.S., Vergarajauregui S., Tsuchiya Y., Hernandez-Tiedra S., Sandoval I.V. Daxx functions as a scaffold of a protein assembly constituted by GLUT4, JNK1 and KIF5B. J. Cell. Physiol. 2009, 218:416-426.
40. Cordero-Reyes A.M., Gupte A.A., Youker K.A., Loebe M., Hsueh W.A., Torre-Amione G., et al. Freshly isolated mitochondria from failing human hearts exhibit preserved respiratory function. J. Mol. Cell. Cardiol. 2014, 68:98-105.
41. Marin-Garcia J., Goldenthal M.J., Moe G.W. Abnormal cardiac and skeletal muscle mitochondrial function in pacing-induced cardiac failure. Cardiovasc. Res. 2001, 52:103-110.
42. Schoepe M., Schrepper A., Schwarzer M., Osterholt M., Doenst T. Exercise can induce temporary mitochondrial and contractile dysfunction linked to impaired respiratory chain complex activity. Metabolism 2012, 61:117-126.
43. Lemieux H., Semsroth S., Antretter H., Hofer D., Gnaiger E. Mitochondrial respiratory control and early defects of oxidative phosphorylation in the failing human heart. Int. J. Biochem. Cell Biol. 2011, 43:1729-1738.
44. Hofer A., Wenz T. Post-translational modification of mitochondria as a novel mode of regulation. Exp. Gerontol. 2014, 56:202-220.
45. Shinmura K. Post-translational modification of mitochondrial proteins by caloric restriction: possible involvement in caloric restriction-induced cardioprotection. Trends Cardiovasc. Med. 2013, 23:18-25.
46. Dudkina N.V., Kouril R., Peters K., Braun H.P., Boekema E.J. Structure and function of mitochondrial supercomplexes. Biochim. Biophys. Acta 1797, 2010:664-670.
47. Beisvag V., Kemi O.J., Arbo I., Loennechen J.P., Wisloff U., Langaas M., et al. Pathological and physiological hypertrophies are regulated by distinct gene programs. Eur. J. Cardiovasc. Prev. Rehabil. 2009, 16:690-697.
48. Drozdov I., Didangelos A., Yin X., Zampetaki A., Abonnenc M., Murdoch C., et al. Gene network and proteomic analyses of cardiac responses to pathological and physiological stress. Circ. Cardiovasc. Genet. 2013, 6:588-597.
49. Riehle C., Wende A.R., Zhu Y., Oliveira K.J., Pereira R.O., Jaishy B.P., et al. Insulin receptor substrates are essential for the bioenergetic and hypertrophic response of the heart to exercise training. Mol. Cell. Biol. 2014, 34:3450-3460.
50. Zhang Y., Yuan M., Bradley K.M., Dong F., Anversa P., Ren J. Insulin-like growth factor 1 alleviates high-fat diet-induced myocardial contractile dysfunction: role of insulin signaling and mitochondrial function. Hypertension 2012, 59:680-693.
51. Javadov S., Rajapurohitam V., Kilic A., Hunter J.C., Zeidan A., Said Faruq N., et al. Expression of mitochondrial fusion-fission proteins during post-infarction remodeling: the effect of NHE-1 inhibition. Basic Res. Cardiol. 2011, 106:99-109.
52. Hollander J.M., Thapa D., Shepherd D.L. Physiological and structural differences in spatially distinct subpopulations of cardiac mitochondria: influence of cardiac pathologies. Am. J. Physiol. Heart Circ. Physiol. 2014, 307:H1-14.